US Stock MarketDetailed Quotes

Dermata Therapeutics (DRMA)

Watchlist
  • 1.220
  • +0.010+0.83%
Close Apr 10 16:00 ET
  • 1.222
  • +0.002+0.13%
Post 18:03 ET
4.91MMarket Cap-0.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dermata Therapeutics (DRMA) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
137.92%7.52M
137.92%7.52M
-24.08%4.66M
31.00%6.48M
105.32%9.72M
-57.50%3.16M
-57.50%3.16M
-7.35%6.14M
-41.37%4.95M
-46.00%4.73M
-Cash and cash equivalents
137.92%7.52M
137.92%7.52M
-24.08%4.66M
31.00%6.48M
105.32%9.72M
-57.50%3.16M
-57.50%3.16M
-7.35%6.14M
-41.37%4.95M
-46.00%4.73M
Prepaid assets
-8.18%341.85K
-8.18%341.85K
-33.51%361.46K
-55.96%76.05K
-52.87%210.23K
-31.12%372.32K
-31.12%372.32K
-21.43%543.59K
-36.87%172.7K
-14.54%446.08K
Current deferred assets
----
----
----
----
----
----
----
----
--116.76K
----
Other current assets
----
----
--45.83K
--83.53K
--75.51K
----
----
----
----
----
Total current assets
122.53%7.86M
122.53%7.86M
-24.16%5.07M
26.81%6.64M
93.16%10.01M
-55.71%3.53M
-55.71%3.53M
-8.69%6.69M
-39.90%5.24M
-44.27%5.18M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
122.53%7.86M
122.53%7.86M
-24.16%5.07M
26.81%6.64M
93.16%10.01M
-55.71%3.53M
-55.71%3.53M
-8.69%6.69M
-39.90%5.24M
-44.27%5.18M
Liabilities
Current liabilities
Payables
-42.97%460.81K
-42.97%460.81K
-47.50%453.43K
-68.83%413.69K
69.63%1.4M
-6.70%808.01K
-6.70%808.01K
82.02%863.6K
203.16%1.33M
66.89%822.55K
-accounts payable
-42.97%460.81K
-42.97%460.81K
-47.50%453.43K
-68.83%413.69K
69.63%1.4M
-6.70%808.01K
-6.70%808.01K
82.02%863.6K
203.16%1.33M
66.89%822.55K
Current accrued expenses
-53.78%200.18K
-53.78%200.18K
-91.56%63.74K
-61.10%121.88K
8.89%346.71K
953.95%433.15K
953.95%433.15K
566.57%755.29K
396.35%313.28K
-45.38%318.41K
Current liabilities
-16.85%1.64M
-16.85%1.64M
-42.90%1.11M
-46.50%1.03M
97.10%2.7M
21.51%1.97M
21.51%1.97M
112.27%1.95M
180.94%1.92M
13.65%1.37M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-16.85%1.64M
-16.85%1.64M
-42.90%1.11M
-46.50%1.03M
97.10%2.7M
21.51%1.97M
21.51%1.97M
112.27%1.95M
180.94%1.92M
13.65%1.37M
Shareholders'equity
Share capital
964.00%266
964.00%266
-50.00%84
-7.25%64
-9.46%603
-3.85%25
-3.85%25
-47.34%168
-78.37%69
178.66%666
-common stock
964.00%266
964.00%266
-50.00%84
-7.25%64
-9.46%603
-3.85%25
-3.85%25
-47.34%168
-78.37%69
178.66%666
-Preferred stock
----
----
--0
----
----
----
----
----
----
----
Retained earnings
-11.51%-73.23M
-11.51%-73.23M
-14.15%-71.37M
-17.40%-69.68M
-20.27%-67.98M
-23.02%-65.68M
-23.02%-65.68M
-21.99%-62.52M
-19.82%-59.35M
-18.16%-56.52M
Paid-in capital
18.18%79.46M
18.18%79.46M
11.99%75.33M
20.15%75.29M
24.78%75.28M
12.54%67.24M
12.54%67.24M
16.66%67.27M
8.87%62.67M
7.88%60.33M
Total stockholders'equity
298.66%6.22M
298.66%6.22M
-16.48%3.96M
69.20%5.61M
91.73%7.3M
-75.44%1.56M
-75.44%1.56M
-25.99%4.74M
-58.68%3.32M
-52.92%3.81M
Total equity
298.66%6.22M
298.66%6.22M
-16.48%3.96M
69.20%5.61M
91.73%7.3M
-75.44%1.56M
-75.44%1.56M
-25.99%4.74M
-58.68%3.32M
-52.92%3.81M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 137.92%7.52M137.92%7.52M-24.08%4.66M31.00%6.48M105.32%9.72M-57.50%3.16M-57.50%3.16M-7.35%6.14M-41.37%4.95M-46.00%4.73M
-Cash and cash equivalents 137.92%7.52M137.92%7.52M-24.08%4.66M31.00%6.48M105.32%9.72M-57.50%3.16M-57.50%3.16M-7.35%6.14M-41.37%4.95M-46.00%4.73M
Prepaid assets -8.18%341.85K-8.18%341.85K-33.51%361.46K-55.96%76.05K-52.87%210.23K-31.12%372.32K-31.12%372.32K-21.43%543.59K-36.87%172.7K-14.54%446.08K
Current deferred assets ----------------------------------116.76K----
Other current assets ----------45.83K--83.53K--75.51K--------------------
Total current assets 122.53%7.86M122.53%7.86M-24.16%5.07M26.81%6.64M93.16%10.01M-55.71%3.53M-55.71%3.53M-8.69%6.69M-39.90%5.24M-44.27%5.18M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets 122.53%7.86M122.53%7.86M-24.16%5.07M26.81%6.64M93.16%10.01M-55.71%3.53M-55.71%3.53M-8.69%6.69M-39.90%5.24M-44.27%5.18M
Liabilities
Current liabilities
Payables -42.97%460.81K-42.97%460.81K-47.50%453.43K-68.83%413.69K69.63%1.4M-6.70%808.01K-6.70%808.01K82.02%863.6K203.16%1.33M66.89%822.55K
-accounts payable -42.97%460.81K-42.97%460.81K-47.50%453.43K-68.83%413.69K69.63%1.4M-6.70%808.01K-6.70%808.01K82.02%863.6K203.16%1.33M66.89%822.55K
Current accrued expenses -53.78%200.18K-53.78%200.18K-91.56%63.74K-61.10%121.88K8.89%346.71K953.95%433.15K953.95%433.15K566.57%755.29K396.35%313.28K-45.38%318.41K
Current liabilities -16.85%1.64M-16.85%1.64M-42.90%1.11M-46.50%1.03M97.10%2.7M21.51%1.97M21.51%1.97M112.27%1.95M180.94%1.92M13.65%1.37M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -16.85%1.64M-16.85%1.64M-42.90%1.11M-46.50%1.03M97.10%2.7M21.51%1.97M21.51%1.97M112.27%1.95M180.94%1.92M13.65%1.37M
Shareholders'equity
Share capital 964.00%266964.00%266-50.00%84-7.25%64-9.46%603-3.85%25-3.85%25-47.34%168-78.37%69178.66%666
-common stock 964.00%266964.00%266-50.00%84-7.25%64-9.46%603-3.85%25-3.85%25-47.34%168-78.37%69178.66%666
-Preferred stock ----------0----------------------------
Retained earnings -11.51%-73.23M-11.51%-73.23M-14.15%-71.37M-17.40%-69.68M-20.27%-67.98M-23.02%-65.68M-23.02%-65.68M-21.99%-62.52M-19.82%-59.35M-18.16%-56.52M
Paid-in capital 18.18%79.46M18.18%79.46M11.99%75.33M20.15%75.29M24.78%75.28M12.54%67.24M12.54%67.24M16.66%67.27M8.87%62.67M7.88%60.33M
Total stockholders'equity 298.66%6.22M298.66%6.22M-16.48%3.96M69.20%5.61M91.73%7.3M-75.44%1.56M-75.44%1.56M-25.99%4.74M-58.68%3.32M-52.92%3.81M
Total equity 298.66%6.22M298.66%6.22M-16.48%3.96M69.20%5.61M91.73%7.3M-75.44%1.56M-75.44%1.56M-25.99%4.74M-58.68%3.32M-52.92%3.81M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On the morning of the 11th local time, Pakistani officials confirmed that delegations from the United States and Iran will hold negotiations Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -